{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:36:52Z","timestamp":1777041412481,"version":"3.51.4"},"reference-count":3,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00106-026-01754-0","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:32:56Z","timestamp":1776335576000},"page":"303-304","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Kurzkommentar zum Cochrane Review 2023 zur Betahistin-Therapie bei M.\u00a0Meni\u00e8re","Brief commentary on the 2023 Cochrane review on betahistine therapy in Meniere\u2019s disease"],"prefix":"10.1007","volume":"74","author":[{"given":"Robert","family":"G\u00fcrkov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"issue":"3","key":"1754_CR1","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003670","volume":"2023","author":"KE Webster","year":"2023","unstructured":"Webster\u00a0KE, van Esch\u00a0BF, van der Zaag-Loonen\u00a0HJ, Pullens\u00a0B, van Benthem\u00a0PPG (2023) Pharmacological interventions for M\u00e9ni\u00e8re\u2019s disease. Cochrane Database of Systematic Reviews 2023(3):CD015395","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"1754_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h6816","volume":"352","author":"C Adrion","year":"2016","unstructured":"Adrion\u00a0C, Fischer\u00a0CS, Wagner\u00a0J, G\u00fcrkov\u00a0R, Mansmann\u00a0U, Strupp\u00a0M (2016) Efficacy and safety of betahistine treatment in patients with M\u00e9ni\u00e8re\u2019s disease (BEMED): a\u00a0double-blind, randomised, placebo-controlled, dose-defining trial. BMJ 352:h6816","journal-title":"BMJ"},{"key":"1754_CR3","doi-asserted-by":"publisher","unstructured":"G\u00fcrkov\u00a0R (2026) Factual errors in the Cochrane review (Webster et al, 2023) on betahistine in Meni\u00e8re\u2019s Disease. Zenodo. https:\/\/doi.org\/10.5281\/zenodo.18497234","DOI":"10.5281\/zenodo.18497234"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-026-01754-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00106-026-01754-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-026-01754-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:30:52Z","timestamp":1777033852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00106-026-01754-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":3,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1754"],"URL":"https:\/\/doi.org\/10.1007\/s00106-026-01754-0","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"13 March 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.\u00a0G\u00fcrkov ist Mitautor der BEMED-Studie sowie der AWMF-Leitlinie \u201eVestibul\u00e4re St\u00f6rungen\u201c.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}